Corporate insider profile
Christoph Rudiger Antz Insider Trades
Latest reported as Chief Executive Officer of Veraxa Biotech AG - Post de-SPAC (VRXA).
- Purchase filings
- 1
- Reported companies
- 1
- Net open-market value
- $7,650
- Latest transaction
- Aug 27, 2026
Affiliated corporations
Reported company relationships
Transaction history
